ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 197,67
0,29%
Dow Jones
42 579,08
-0,99%
DAX
23 419,48
1,30%
Brent Oil
69,34
0,00%
Bitcoin
87 449,21
-2,75%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Penumbra Inc (PEN)

  7. Penumbra Inc (PEN) Actualités

PEN

Penumbra (PEN)

Penumbra Inc
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:PEN
DateHeureSourceTitreSymboleSociété
06/03/202501h37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PENPenumbra Inc
05/03/202522h27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:PENPenumbra Inc
21/02/202522h17Edgar (US Regulatory)Form 8-K - Current reportNYSE:PENPenumbra Inc
21/02/202522h05PR Newswire (US)Penumbra, Inc. Announces Don Kassing will Retire from Board of DirectorsNYSE:PENPenumbra Inc
18/02/202522h44Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:PENPenumbra Inc
18/02/202522h05PR Newswire (US)Penumbra, Inc. Reports Fourth Quarter and Full Year 2024 Financial ResultsNYSE:PENPenumbra Inc
21/01/202522h30PR Newswire (US)Penumbra, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call for February 18, 2025NYSE:PENPenumbra Inc
30/12/202422h30PR Newswire (US)Penumbra, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNYSE:PENPenumbra Inc
20/11/202422h30PR Newswire (US)Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare ConferenceNYSE:PENPenumbra Inc
12/11/202418h53Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NYSE:PENPenumbra Inc
05/11/202415h00PR Newswire (US)New Late Breaking Data Show Patients Treated with Penumbra's Computer Assisted Vacuum Thrombectomy Technology for Pulmonary Embolism Experience Shorter Hospital Stays and Fewer Complications Compared to Other Treatment OptionsNYSE:PENPenumbra Inc
30/10/202421h47Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:PENPenumbra Inc
30/10/202421h05PR Newswire (US)Penumbra, Inc. Reports Third Quarter 2024 Financial ResultsNYSE:PENPenumbra Inc
14/10/202415h00PR Newswire (US)Penumbra, Inc. Announces Completion of THUNDER IDE Study Enrollment for Acute Ischemic StrokeNYSE:PENPenumbra Inc
02/10/202422h30PR Newswire (US)Penumbra, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for October 30, 2024NYSE:PENPenumbra Inc
16/09/202409h00PR Newswire (US)Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flash™ 2.0 and Lightning Bolt™ 7 - in EuropeNYSE:PENPenumbra Inc
27/08/202422h30PR Newswire (US)Penumbra, Inc. to Present at the Baird Global Healthcare ConferenceNYSE:PENPenumbra Inc
21/08/202422h30PR Newswire (US)Penumbra, Inc. to Present at the Wells Fargo Healthcare ConferenceNYSE:PENPenumbra Inc
13/08/202413h00PR Newswire (US)Penumbra, Inc. Announces $200 Million Share Repurchase AuthorizationNYSE:PENPenumbra Inc
02/08/202422h30PR Newswire (US)Penumbra, Inc. to Present at the Canaccord Genuity Growth ConferenceNYSE:PENPenumbra Inc
30/07/202422h05PR Newswire (US)Penumbra, Inc. Reports Second Quarter 2024 Financial ResultsNYSE:PENPenumbra Inc
02/07/202422h05PR Newswire (US)Penumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024NYSE:PENPenumbra Inc
04/06/202422h30PR Newswire (US)Penumbra, Inc. to Present at the Truist Securities MedTech ConferenceNYSE:PENPenumbra Inc
31/05/202422h39Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:PENPenumbra Inc
23/05/202422h30PR Newswire (US)Penumbra, Inc. to Present at the William Blair Growth Stock ConferenceNYSE:PENPenumbra Inc
07/05/202422h05PR Newswire (US)Penumbra, Inc. Reports First Quarter 2024 Financial ResultsNYSE:PENPenumbra Inc
01/05/202422h05PR Newswire (US)Penumbra, Inc. to Present at the RBC Capital Markets Global Healthcare ConferenceNYSE:PENPenumbra Inc
23/04/202415h00PR Newswire (US)Penumbra Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood ClotsNYSE:PENPenumbra Inc
09/04/202422h05PR Newswire (US)Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024NYSE:PENPenumbra Inc
22/02/202422h05PR Newswire (US)Penumbra, Inc. Reports Fourth Quarter and Full Year 2023 Financial ResultsNYSE:PENPenumbra Inc
 Showing the most relevant articles for your search:NYSE:PEN

Dernières Valeurs Consultées

BIT
S29659
Societe Generale Effekten
BIT
FFGC
Global Government Bond C...
NYSE
HIMS
Hims and Hers Health
LSE
42OV
Mercantile6.125
LSE
62ZW
Rhp Fin 48
EU
OTEL
Republic of Portugal 0.4...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces